DUBLIN, Sept. 07, 2022 (GLOBE NEWSWIRE) — The Laxatives Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 report has been added ResearchAndMarkets.com Offer.
The global laxatives market is growing at a substantial pace and is projected to grow at a CAGR of 5.5% over the estimated period 2022-2030 from US$6,063.8 million in 2021.
Constipation is one of the most common disorders diagnosed in clinical practice, with up to one fifth of the general population suffering from chronic constipation. Certain studies have reported a prevalence of 24% to 50% in older adults. It is also observed that between 10% and 18% of geriatrics in communal accommodation and 74% of residents in nursing homes regularly use laxatives.
Constipation can significantly impair patients’ daily functions and quality of life. Severe cases of constipation can also lead to coronary episodes, cerebral ischemia and syncope. To mitigate the complications arising from uncontrolled or unmanaged constipation, various types of laxatives are often prescribed to such patients, particularly those belonging to the older age group.
Constipation can be treated with home remedies like fiber, regular exercise, and increasing fluid intake. Home remedies are effective in treating mild cases of constipation. However, laxatives are the drugs used to treat both severe and mild cases of constipation. These laxatives have different mechanisms for curing constipation and have different variations from one drug to another.
Drug classes, including psyllium and methylcellulose, work by increasing bulk in the stool, producing a result that causes bowel movement. Therefore, these drug classes are also referred to as bulk-forming laxatives. In addition, some medications work by accumulating the volume of water in the stool, making the stool looser and easier to pass. Drug compounds such as senna and bisacodyl are known as stimulant laxatives. Stimulant laxatives work by inducing a bowel movement by acting to speed up bowel muscle movement.
Additionally, lockdown restrictions and the need to maintain social distancing due to the ongoing COVID-19 pandemic have resulted in more people staying at home. Therefore, a sedentary lifestyle has led to the development of chronic constipation. Moreover, the increasing demand for junk food drastically alters the peristaltic activity of the intestines, resulting in hardening of the stool, so the laxatives market is anticipated to witness significant growth during the forecast period, 2022 to 2030.
The increasing demand for junk food will boost the laxative market in North America
In 2021, North America dominated the regional laxatives market as all major Rx and OTC laxatives have a strong presence, greater awareness of constipation and its rapid treatment are the main factors contributing to the prominent position of not only laxatives but the overall digestive aid drug market in North America. The presence of large market players such as Bayer AG, Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline, Plc. and others continue to support positive market growth in the region.
The increasing geriatric pool will boost the Asia Pacific market
The Asia Pacific region is expected to be the fastest growing region over the forecast period due to the increasing geriatric pool with altered peristaltic bowel activity. In addition, the constant increase in sedentary lifestyles and growing propensity to eat fast food will further boost the market growth in Asia-Pacific region. This report is a comprehensive research study of the global Laxatives Market that elaborates the key trends in the market based on quantitative and qualitative research. This report provides a detailed description of the global Laxatives market segmentation by drug types and geography. This report helps market players to make improved decisions and strategies in the Laxatives market.
Historical – forecast period
This study report presents an analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.
The current report includes quantitative market estimates for each micro market for each geographic region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segmental analysis, Porter’s Five Force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations, and other key market insights.
Key questions answered in this report
- What are the major micro and macro environmental factors affecting the growth of the Laxatives market?
- What are the key investment pockets in terms of product segments and regions currently and during the forecast period?
- Estimated Forecast and Market Forecasts to 2030.
- Which segment will exhibit the fastest CAGR over the forecast period?
- Which market segment holds a larger market share and why?
- Are Low and Middle Income Economies Investing in the Laxatives Market?
- What is the largest regional market for Laxatives Market?
- What are the market trends and dynamics in emerging markets like Asia Pacific, Latin America and Middle East – Africa?
- What are the key trends driving the growth of the Laxatives market?
- Who are the major competitors and what are the key strategies they are pursuing to increase their market presence in the Laxatives market globally?
Main topics covered:
3. Laxatives Market: Business Outlook and Market Dynamics
3.2. Global Laxatives Market Value, 2020-2030, (Million US$)
3.3. market dynamics
3.3.1. market leader
3.3.2. Market Restrictions
3.3.3. key challenge
3.3.4. key opportunities
3.4. Impact analysis of drivers and constraints
3.5. seesaw analysis
3.6. Porter’s Five Forces Model
3.6.1. supplier performance
3.6.2. buyer power
3.6.3. threat of substitutes
3.6.4. Threat of newcomers
3.7. PESTEL analysis
3.7.1. political landscape
3.7.2. economic landscape
3.7.3. technology landscape
3.7.4. legal landscape
3.7.5. social landscape
3.8. Heptalysis Analysis
3.9. Critical examination of business problems through five why root cause analysis and relevant solutions
4. Laxatives Market: By Drug Type, 2020-2030, USD (Million)
4.1. Market Overview
4.2. Growth and Revenue Analysis: 2021 versus 2030
4.3. market segmentation
4.3.1. crowd builder
4.3.2. Emollients (stool softeners)
4.3.4. Stimulant Agents
4.3.5. Hyperosmotic Agents
4.3.6. Saline laxatives
4.3.7. Chloride Channel Activators
5. Laxatives Market: By Availability, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth and Revenue Analysis: 2021 versus 2030
5.3. market segmentation
5.3.1. Over the counter (OTC)
6. Laxatives Market: By Route of Administration, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Growth and Revenue Analysis: 2021 versus 2030
6.3. market segmentation
7. North America Laxatives Market, 2020-2030, USD (Million)
8. UK & European Union Laxatives Market, 2020-2030, USD (Million)
9. Asia Pacific Laxatives Market, 2020-2030, USD (Million)
10. Latin America Laxatives Market, 2020-2030, USD (Million)
11. Middle East and Africa Laxatives Market, 2020-2030, USD (Million)
12. Company Profile
12.1. Bayer AG
12.1.1. company overview
12.1.2. financial performance
12.1.3. product portfolio
12.1.4. Strategic Initiatives
12.2. Boehringer Ingelheim Pharmaceuticals, Inc.
12.2.1. company overview
12.2.2. financial performance
12.2.3. product portfolio
12.2.4. Strategic Initiatives
12.3. Braintree Laboratories, Inc.
12.3.1. company overview
12.3.2. financial performance
12.3.3. product portfolio
12.3.4. Strategic Initiatives
12.4. GlaxoSmithKline Consumer Healthcare, LP
12.4.1. company overview
12.4.2. financial performance
12.4.3. product portfolio
12.4.4. Strategic Initiatives
12.5. Procter & Gamble company
12.5.1. company overview
12.5.2. financial performance
12.5.3. product portfolio
12.5.4. Strategic Initiatives
12.6. Purdue Pharma LP
12.6.1. company overview
12.6.2. financial performance
12.6.3. product portfolio
12.6.4. Strategic Initiatives
12.7. Sucampo Pharmaceuticals, Inc.
12.7.1. company overview
12.7.2. financial performance
12.7.3. product portfolio
12.7.4. Strategic Initiatives
For more information about this report, visit https://www.researchandmarkets.com/r/kjh3do